Role of fibrillation cycle length in spontaneous and drug-induced termination of human atrial fibrillation.

The aim of this study was to investigate the mechanism of spontaneous termination of atrial fibrillation (AF) by comparing it with drug-induced termination on the basis of changes in fibrillation cycle length (FCL). Fast Fourier transform analysis was carried out on the electrocardiogram (ECG) records of 27 patients with paroxysmal AF without organic heart disease. In 8 patients with drug-induced termination of AF, spectral analysis of the data from surface ECG lead V1 was performed before and after class I antiarrhythmic drug infusion for 10 min. In 19 patients with spontaneous termination of AF, the analysis used the Holter ECG recordings at 10 min before the spontaneous termination and at the termination. FCL was calculated from the peak frequency of each epoch and the mean FCL and the coefficient of variation (CV) of FCL were determined from the data of 20 epochs. In the 8 episodes of drug-induced AF termination, the mean FCL increased significantly with class I drugs (from 151+/-17 to 203+/-21 ms, p<0.001), whereas in the 19 episodes of spontaneous termination, the mean FCL and CV of FCL at termination did not differ from those at 10 min before the termination. Of the 19 episodes, 10 episodes terminating in the morning showed a significant increase in the FCL of the last epoch of the termination period (from 158 +/-22 to 172+/-17 ms, p<0.05). In the 9 episodes terminating in either the afternoon or the evening, the FCL of the last epoch did not change significantly. Although drug-induced termination of paroxysmal AF may depend on a gradual increase in FCL, the pattern of spontaneous termination may depend on the time of day. Spontaneous termination in the morning may be caused by an abrupt increase in FCL related to vagolytic autonomic balance.

[1]  L. Sörnmo,et al.  Non-invasive assessment of the atrial cycle length during atrial fibrillation in man: introducing, validating and illustrating a new ECG method. , 1998, Cardiovascular research.

[2]  A. Bollmann,et al.  Frequency analysis of human atrial fibrillation using the surface electrocardiogram and its response to ibutilide. , 1998, The American journal of cardiology.

[3]  D. Haines,et al.  Electrical, Morphological, and Ultrastructural Remodeling and Reverse Remodeling in a Canine Model of Chronic Atrial Fibrillation , 2000, Circulation.

[4]  S. Niwano,et al.  Inhomogeneity in the appearance of electrical remodeling during chronic rapid atrial pacing: evaluation of the dispersion of atrial effective refractoriness. , 2001, Japanese circulation journal.

[5]  A. Sahakian,et al.  Computer Discrimination of Atrial Fibrillation and Regular Atrial Rhythms from Intra‐Atrial Electrograms , 1988, Pacing and clinical electrophysiology : PACE.

[6]  M. Osaka,et al.  Quantitative analysis of termination of vagally induced canine atrial fibrillation by mutual information. , 2001, Japanese circulation journal.

[7]  J Clémenty,et al.  Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. , 1998, The New England journal of medicine.

[8]  H. Inoue,et al.  Efficacy of class Ia antiarrhythmic drugs in converting atrial fibrillation unassociated with organic heart disease and their relation to atrial electrophysiologic characteristics. , 1994, The American journal of cardiology.

[9]  M. Allessie,et al.  The Wavelength of the Cardiac Impulse and Reentrant Arrhythmias in Isolated Rabbit Atrium: The Role of Heart Rate, Autonomic Transmitters, Temperature, and Potassium , 1986, Circulation research.

[10]  S Nattel,et al.  Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness. , 1993, Circulation.

[11]  M. Allessie,et al.  Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol. , 2000, Circulation.

[12]  M. Allessie,et al.  Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. , 1995, Circulation.

[13]  G. Klein,et al.  Termination of acute atrial fibrillation in the Wolff-Parkinson-White syndrome by procainamide and propafenone: importance of atrial fibrillatory cycle length. , 1990, Journal of the American College of Cardiology.

[14]  M. Allessie,et al.  Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation. , 1997, Circulation.

[15]  S Swiryn,et al.  Observations From Intraatrial Recordings on the Termination of Electrically Induced Atrial Fibrillation in Humans , 1994, Pacing and clinical electrophysiology : PACE.

[16]  F. Morady,et al.  Effect of atrial fibrillation on atrial refractoriness in humans. , 1996, Circulation.

[17]  N. Kouchoukos,et al.  Characterization of Atrial Fibrillation in Man: Studies Following Open Heart Surgery * , 1978, Pacing and clinical electrophysiology : PACE.

[18]  P Coumel,et al.  Clinical approach to paroxysmal atrial fibrillation , 1990, Clinical cardiology.

[19]  M. Allessie,et al.  High-density mapping of electrically induced atrial fibrillation in humans. , 1994, Circulation.

[20]  A Fujiki,et al.  Spectral characteristics of human atrial fibrillation waves of the right atrial free wall with respect to the duration of atrial fibrillation and effect of class I antiarrhythmic drugs. , 2001, Japanese circulation journal.

[21]  Douglas L. Jones,et al.  Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. , 1995, Circulation.